350 related articles for article (PubMed ID: 38338378)
1. Drug Repurposing in the Chemotherapy of Infectious Diseases.
Hamid A; Mäser P; Mahmoud AB
Molecules; 2024 Jan; 29(3):. PubMed ID: 38338378
[TBL] [Abstract][Full Text] [Related]
2. Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease.
Montoya MC; Krysan DJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30563895
[TBL] [Abstract][Full Text] [Related]
3. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
Ng YL; Salim CK; Chu JJH
Pharmacol Ther; 2021 Dec; 228():107930. PubMed ID: 34174275
[TBL] [Abstract][Full Text] [Related]
4. Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access.
Greenblatt W; Gupta C; Kao J
Health Aff (Millwood); 2023 Mar; 42(3):424-432. PubMed ID: 36877896
[TBL] [Abstract][Full Text] [Related]
5. High Throughput and Computational Repurposing for Neglected Diseases.
Hernandez HW; Soeung M; Zorn KM; Ashoura N; Mottin M; Andrade CH; Caffrey CR; de Siqueira-Neto JL; Ekins S
Pharm Res; 2018 Dec; 36(2):27. PubMed ID: 30560386
[TBL] [Abstract][Full Text] [Related]
6. A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19.
Martin JH; Head R
Br J Clin Pharmacol; 2021 Mar; 87(3):875-885. PubMed ID: 32959913
[TBL] [Abstract][Full Text] [Related]
7. A New Approach to Drug Repurposing with Two-Stage Prediction, Machine Learning, and Unsupervised Clustering of Gene Expression.
Cong Y; Shintani M; Imanari F; Osada N; Endo T
OMICS; 2022 Jun; 26(6):339-347. PubMed ID: 35666246
[TBL] [Abstract][Full Text] [Related]
8. Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic.
Khadka S; Yuchi A; Shrestha DB; Budhathoki P; Al-Subari SMM; Ziad Alhouzani TM; Anwar Butt I
Altern Ther Health Med; 2020 Aug; 26(S2):100-107. PubMed ID: 32827400
[TBL] [Abstract][Full Text] [Related]
9. Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19.
Norinder U; Tuck A; Norgren K; Munic Kos V
Biomed Pharmacother; 2020 Oct; 130():110582. PubMed ID: 32763818
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns.
Mslati H; Gentile F; Perez C; Cherkasov A
J Chem Inf Model; 2021 Aug; 61(8):3771-3788. PubMed ID: 34313439
[TBL] [Abstract][Full Text] [Related]
11. Repurposed drug candidates for antituberculosis therapy.
An Q; Li C; Chen Y; Deng Y; Yang T; Luo Y
Eur J Med Chem; 2020 Apr; 192():112175. PubMed ID: 32126450
[TBL] [Abstract][Full Text] [Related]
12. Repurposing anticancer drugs for the management of COVID-19.
El Bairi K; Trapani D; Petrillo A; Le Page C; Zbakh H; Daniele B; Belbaraka R; Curigliano G; Afqir S
Eur J Cancer; 2020 Dec; 141():40-61. PubMed ID: 33125946
[TBL] [Abstract][Full Text] [Related]
13. Drug repurposing screens and synergistic drug-combinations for infectious diseases.
Zheng W; Sun W; Simeonov A
Br J Pharmacol; 2018 Jan; 175(2):181-191. PubMed ID: 28685814
[TBL] [Abstract][Full Text] [Related]
14. Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19.
Cong Y; Endo T
OMICS; 2022 Jul; 26(7):361-371. PubMed ID: 35759424
[TBL] [Abstract][Full Text] [Related]
15. A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics.
Wattanakul T; Chotsiri P; Scandale I; Hoglund RM; Tarning J
Expert Rev Clin Pharmacol; 2022 Aug; 15(8):945-958. PubMed ID: 36017624
[TBL] [Abstract][Full Text] [Related]
16. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
17. Can drug repurposing strategies be the solution to the COVID-19 crisis?
Bellera CL; Llanos M; Gantner ME; Rodriguez S; Gavernet L; Comini M; Talevi A
Expert Opin Drug Discov; 2021 Jun; 16(6):605-612. PubMed ID: 33345645
[No Abstract] [Full Text] [Related]
18. Role of ACE2 receptor and the landscape of treatment options from convalescent plasma therapy to the drug repurposing in COVID-19.
Kumar P; Sah AK; Tripathi G; Kashyap A; Tripathi A; Rao R; Mishra PC; Mallick K; Husain A; Kashyap MK
Mol Cell Biochem; 2021 Feb; 476(2):553-574. PubMed ID: 33029696
[TBL] [Abstract][Full Text] [Related]
19. Utilizing drug repurposing against COVID-19 - Efficacy, limitations, and challenges.
Parvathaneni V; Gupta V
Life Sci; 2020 Oct; 259():118275. PubMed ID: 32818545
[TBL] [Abstract][Full Text] [Related]
20. Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic.
Schindell BG; Allardice M; Lockman S; Kindrachuk J
ACS Infect Dis; 2021 Jun; 7(6):1303-1316. PubMed ID: 33319978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
